In theory, patents are supposed to grant pharmaceutical companies a reward for investing in research and development.
But in practice, patenting minor tweaks to a formula can extend this term considerably, foreclosing market competition and granting pharmaceutical companies the power to set prices.
In 1996, a treatment for HIV/Aids was brought to market in the US by a clutch of pharmaceutical companies.
Already weâ€™ve seen how medical monopolies have restricted access to coronavirus treatments.
If Covid-19 treatments were free from monopoly control, we would have a real shot at reaching everyone.